Breast augmentation with implants is one of the most popular plastic surgery procedures. Experience and clinical observations have revealed an association between breast augmentation with implants and a special type of lymphoma that occurs around them - breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL), which resulted in changing of the selection criteria for implant and restrictive measures in several countries. The authors present the first case of breast-implant-associated anaplastic large-cell lymphoma in Belarus. Breast implant augmentation-mastopexy for cosmetic reasons had been performed 9 years before the diagnosis of lymphoma made. The implants of the 3rd group of texture according to ISO classification were used. The disease manifested with seroma of the right breast. Prior the surgery (capsulectomy and reaugmentation with implants) due to the patient’s refusal to undergo the surgical treatment, several aspirations to obtain fluid for analysis to diagnose were performed. Final diagnosis was BIA-ALCL, stage 1a. The patient has been followed up for 1,5 years and there was no recurrence. This study provides a literature review of recent scientific publications concerning this issue and testifies an increase in the number of cases, the majority of them manifest themselves only as seroma, and total capsulectomy is a sufficient and final treatment. Today the presence of breast implants without definite symptoms is not an indication for implant removal or replacement. The authors consider it rational to create a national registry of implants with the aim of an analytical approach to possible associations with pathological conditions.